Five ways in. One way out.
The real mechanics of hyperpigmentation on melanated skin, and why the mark outlasts the moment that caused it.
A bump heals in days. A razor slip closes on its own. A single pimple, left alone, fades. The mark any of the three leaves behind can still be sitting there next summer.
That gap, between how fast the injury heals and how long the color stays, is the whole subject of this guide. Almost nobody explains why the gap exists. Not because it is a secret, but because a mechanism does not fit on a label, and a jar that promises to fade dark marks sells fine without one.
Here is the mechanism.
PIH changes only the color. Nothing is missing and nothing is thickened.
Post-inflammatory hyperpigmentation, PIH for short, is not a scar. A scar changes the texture of skin: a pit, a raised line, a patch that feels different under a finger. PIH changes only the color. Nothing is missing and nothing is thickened. A melanocyte, the cell responsible for producing pigment, simply made more of it than the injury needed, or handed more of it to nearby skin cells than it should have, in response to damage that has often already healed.
That distinction is also why PIH is treatable at all. A true scar is structural, and structure is hard to undo. Pigment is not structural. It can be slowed at the source, blocked in transit, or cleared out along with the cells carrying it. That is the good news. It is also why a mark that could resolve in eight weeks with the right approach is instead still visible two years later with the wrong one, or with none at all.
Our skin does not grade the source. It responds to the fact of inflammation.
Melanated skin, Fitzpatrick types four through six, does not have more melanocytes than lighter skin. It has melanocytes that are easier to provoke, and once provoked, they overproduce by a wider margin than the same injury triggers in someone with Fitzpatrick two or three skin. That is why a bump a lighter-skinned reader forgets about by Friday can mark us into next year.
The inflammation does not need an obvious injury as its source. It can come from a new active introduced too fast, from over-exfoliation, from a condition mistreated because it was never actually acne, or from the ordinary friction of a razor against curled hair. Our skin does not grade the source. It responds to the fact of inflammation, whatever caused it, which is why a routine calibrated for a different reactivity curve so often leaves us worse than it found us.
A mark that could resolve in eight weeks with the right approach is still visible two years later with the wrong one.
There is no single fix because there is no single mechanism.
There is no single fix for PIH because there is no single mechanism producing it. There are five, and knowing which one an ingredient works on is the difference between a routine that helps and one that is expensive maintenance.
Pick a lever. Watch what happens to the mark already there.
Two of the five act before pigment exists at all. Tyrosinase is the enzyme that manufactures melanin, and azelaic acid, kojic acid, and vitamin C all block it to varying degrees. Azelaic acid does four jobs at once: antibacterial, pore-clearing, anti-inflammatory, and tyrosinase-inhibiting, which means it treats the inflammation and the pigment response together, not just the pigment. For decades, tyrosinase-inhibitor research was screened against mushroom tyrosinase, which is cheap and convenient and not the enzyme actually at work in human skin. Newer ingredients bred against the human enzyme, like thiamidol, are closing that gap: an independent Brazilian trial of fifty participants, most of them Fitzpatrick three or four skin, found no significant difference against four percent hydroquinone. That is not proof the two perform the same. It is a real signal that screening against the correct enzyme produces better candidates. Vitamin C and niacinamide work a related angle, quenching the free radicals that provoke melanocytes into overproducing in the first place.
One acts on the handoff. Melanin is made inside the melanocyte, packaged into small units called melanosomes, and passed into surrounding skin cells, the step that actually deposits visible color. Niacinamide blocks that transfer. It does not stop melanin from being made, only how much of it gets delivered.
One acts on the type of pigment itself. Skin produces two kinds of melanin: eumelanin, darker, and pheomelanin, lighter. Glutathione appears to shift production toward the lighter type. This is the newest and least settled of the five mechanisms, and least settled is different from ineffective: the evidence base is thinner, not the biology fake.
And one, only one, acts on pigment already sitting in the skin. Retinoids and alpha hydroxy acids speed the turnover of pigmented skin cells, physically moving them out and replacing them with unmarked ones underneath. This is the mechanism most people actually want when they say they want a mark gone, and the one product marketing quietly skips past, because turnover takes longer to show results than a serum promising brightening by week two.
Four of the five stop new pigment from arriving. Only one clears out what is already there.
A routine built entirely on the first four holds the line against new marks and does almost nothing about the ones already there.
SPF says nothing about visible light.
Sunscreen is not optional on melanated skin. It is also not complete on its own, and almost nobody explains why.
SPF measures protection against UVB, the wavelength responsible for sunburn. It says nothing about visible light, the part of the spectrum you can actually see, and that gap matters more on melanin-rich skin. In one trial of people with melasma, a sunscreen that also blocked visible light produced more improvement in eight weeks than a UV-only sunscreen did, with the rest of the routine held the same. In another, on Fitzpatrick IV skin, iron-oxide formulas blocked the visible-light darkening that an untinted SPF 50 let through. Iron oxide is the ingredient doing that work, and it is rarely the headline on the bottle. A sunscreen can be excellent by every measure on the front and still leave the part of the spectrum that matters most to us unaddressed.
There is a second, quieter reason sunscreen underperforms here, and it has nothing to do with the person wearing it. United States regulation has been slower than other markets to approve newer UV filters, several of which are prized elsewhere for going on sheer instead of chalky or gray. That lag is a real reason American formulas still fight melanated skin on cosmetic elegance, not a formulator failing to try. One such filter, bemotrizinol, cleared FDA approval this past June, the first real movement in a while.
A sunscreen someone resents wearing is a sunscreen they stop wearing, and a stopped sunscreen reopens the exact door this guide is about.
An injury, on our skin, is a pigment event waiting to happen.
Here is the mistake with the shortest distance between good intentions and a new mark: a barrier breach.
Anything that strips or damages the skin's outer barrier, whether an aggressive acid peel, a physical scrub with sharp abrasive particles, or simply too many actives layered on too fast, reads to our skin as an injury. And an injury, on our skin, is a pigment event waiting to happen. At least one at-home peel does not disclose its acid percentage on the packaging at all, leaving the person with no way to judge whether they are applying a gentle step or an aggressive one to their own face with no supervision.
This is not a blanket case against exfoliation, and it should not be flattened into one. There is a real difference between a harsh, sharp-edged scrub that leaves visible micro-tears and a gentler mechanical exfoliant like jojoba beads or colloidal oatmeal, genuinely useful worked into a pre-shave routine on coarse, curling hair to head off ingrown hairs before they start. One is trauma dressed up as skincare. The other is a legitimate tool doing a specific job. The difference is not the category on the label. It is how the product behaves on skin, and whether whoever sold it to you can actually tell you which one you are holding.
The name on the front tells you what is in the room. It does not tell you how much.
One more habit worth building: a hero ingredient's name on the front of a bottle tells you what is in the room. It does not tell you how much, in what form, or whether it can do the specific job you bought it for.
Azelaic acid is a clean example. On the face, brands routinely disclose a real percentage, sometimes naming several forms with a number attached to each. Move to a body lotion, where PIH from body acne or razor bumps is just as real, and that same disclosure gets thin. A derivative of azelaic acid is not a lesser ingredient. A well-formulated derivative can be gentler and easier to spread across a large area than raw acid, which is genuinely unpleasant to wear at a working strength. But a derivative and a disclosed percentage of free acid are not the same claim, and a label that leans on the parent ingredient's name without saying which, or how much, is not giving you the information the front implies.
Ask. A brand that has done the formulation work will have the answer ready.
None of this is vanity.
A mark that lingers for two years because nobody explained the mechanism behind it is not a small thing on skin told for generations to disappear quietly. Looking like ourselves again, without a shadow standing where an old injury used to be, has never been frivolous. It is what dignity has always looked like on skin like ours.
The heritage remedies are not wrong to reach for: the shea butter, the cocoa butter kept by the sink. They do real work sealing a barrier that inflammation can otherwise reopen. They were never built to inhibit an enzyme, block a transfer, or speed a turnover cycle, because that was never their job. Knowing the difference between what soothes skin and what corrects pigment is not a rejection of what came before. It is what lets both do the job they are actually suited for.
A dark mark left behind by a bump, a razor slip, or a breakout is not a scar, and it does not mean our skin failed us. It is melanated skin doing something it is built to do: overcorrect in response to inflammation. That overcorrection runs through five separate biological pathways, and most of what gets sold to treat it only works on one or two of them. This guide walks through what is actually happening under the mark, in plain terms, and where the shelf still has not caught up to skin like ours.
Reign in your skin
The products we have evaluated for dark marks, and what each one actually does, are on the Hyperpigmentation shelf.
Open the Hyperpigmentation shelf →Doctor Djeli is ROOT & REIGN's AI educator, not a licensed medical provider. This is education, not a diagnosis.